These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38531369)

  • 1. VAMP1-Related Congenital Myasthenic Syndrome: A Case Report and Literature Review.
    Yıldırım M; Yarenci GB; Genç MB; Uçar Çİ; Bayav S; Tekin MN; Bektaş Ö; Teber S
    Neuropediatrics; 2024 Jun; 55(3):200-204. PubMed ID: 38531369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome.
    Al-Muhaizea MA; AlQuait L; AlRasheed A; AlHarbi S; Albader AA; AlMass R; Albakheet A; Alhumaidan A; AlRasheed MM; Colak D; Kaya N
    Neuromuscul Disord; 2020 Jul; 30(7):611-615. PubMed ID: 32616363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes - A recognizable clinical phenotype.
    Polavarapu K; Vengalil S; Preethish-Kumar V; Arunachal G; Nashi S; Mohan D; Chawla T; Bardhan M; Nandeesh B; Gupta P; Gowda VK; Lochmüller H; Nalini A
    Eur J Paediatr Neurol; 2021 Mar; 31():54-60. PubMed ID: 33631708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing the Understanding of Vesicle-Associated Membrane Protein 1-Related Congenital Myasthenic Syndrome: Phenotypic Insights, Favorable Response to 3,4-Diaminopyridine, and Clinical Characterization of Five New Cases.
    Natera-de Benito D; Pugliese A; Polavarapu K; Guergueltcheva V; Tournev I; Todorova A; Afonso Ribeiro J; Fernández-Mayoralas DM; Ortez C; Martorell L; Estévez-Arias B; Matalonga L; Laurie S; Jou C; Lau J; Thompson R; Shen X; Engel AG; Nascimento A; Lochmüller H; Selcen D
    Pediatr Neurol; 2024 Aug; 157():5-13. PubMed ID: 38833907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the genetic and phenotypic spectrum of congenital myasthenic syndrome: new homozygous VAMP1 splicing variants in 2 novel individuals.
    Cotrina-Vinagre FJ; Rodríguez-García ME; Del Pozo-Filíu L; Hernández-Laín A; Arteche-López A; Morte B; Sevilla M; Pérez-Jurado LA; Quijada-Fraile P; Camacho A; Martínez-Azorín F
    J Hum Genet; 2024 May; 69(5):187-196. PubMed ID: 38355957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome.
    Salpietro V; Lin W; Delle Vedove A; Storbeck M; Liu Y; Efthymiou S; Manole A; Wiethoff S; Ye Q; Saggar A; McElreavey K; Krishnakumar SS; ; Pitt M; Bello OD; Rothman JE; Basel-Vanagaite L; Hubshman MW; Aharoni S; Manzur AY; Wirth B; Houlden H
    Ann Neurol; 2017 Apr; 81(4):597-603. PubMed ID: 28253535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of congenital myasthenic syndrome caused by a novel compound heterozygous variant in RAPSN.
    Saito M; Ogasawara M; Inaba Y; Osawa Y; Nishioka M; Yamauchi S; Atsumi K; Takeuchi S; Imai K; Motobayashi M; Misawa Y; Iida A; Nishino I
    Brain Dev; 2022 Jan; 44(1):50-55. PubMed ID: 34565654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to Spot Congenital Myasthenic Syndromes Resembling the Lambert-Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features.
    Lorenzoni PJ; Scola RH; Kay CSK; Werneck LC; Horvath R; Lochmüller H
    Neuromolecular Med; 2018 Jun; 20(2):205-214. PubMed ID: 29696584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
    Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
    Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
    Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
    Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital myasthenic syndrome related to SLC25A1 gene variant: two cases report and literature review].
    Li WH; Wu BB; Zhou SZ
    Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):42-46. PubMed ID: 33397003
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGRN Gene Mutation Leads to Congenital Myasthenia Syndromes: A Pediatric Case Report and Literature Review.
    Gan S; Yang H; Xiao T; Pan Z; Wu L
    Neuropediatrics; 2020 Oct; 51(5):364-367. PubMed ID: 32221959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case report of an intermediate phenotype between congenital myasthenic syndrome and D-2- and L-2-hydroxyglutaric aciduria due to novel SLC25A1 variants.
    Li W; Zhang M; Zhang L; Shi Y; Zhao L; Wu B; Li X; Zhou S
    BMC Neurol; 2020 Jul; 20(1):278. PubMed ID: 32660532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique presentation of rapidly fluctuating symptoms in a child with congenital myasthenic syndrome due to RAPSN mutation.
    Kumar A; Asghar S; Kavanagh R; Wicklund MP
    Muscle Nerve; 2018 Oct; 58(4):E23-E24. PubMed ID: 30028532
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
    Kinali M; Beeson D; Pitt MC; Jungbluth H; Simonds AK; Aloysius A; Cockerill H; Davis T; Palace J; Manzur AY; Jimenez-Mallebrera C; Sewry C; Muntoni F; Robb SA
    J Neuroimmunol; 2008 Sep; 201-202():6-12. PubMed ID: 18707767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients.
    Gül Mert G; Özcan N; Hergüner Ö; Altunbaşak Ş; Incecik F; Bişgin A; Ceylaner S
    Acta Neurol Belg; 2021 Apr; 121(2):529-534. PubMed ID: 31773638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
    Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
    Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOK7 congenital myasthenic syndrome: case series and review of literature.
    Ziaadini B; Ghaderi Yazdi B; Dirandeh E; Boostani R; Karimi N; Panahi A; Kariminejad A; Fadaee M; Ahangari F; Nafissi S
    BMC Neurol; 2024 Jun; 24(1):211. PubMed ID: 38907197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
    Rodríguez Cruz PM; Palace J; Beeson D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.